Fly News Breaks for June 22, 2018
SENS
Jun 22, 2018 | 07:29 EDT
Canaccord analyst Kyle Rose said the FDA approval of Senseonics' 90-day Eversense CGM system comes just in time for a major push at this year's ADA conference, which begins tomorrow. He noted the initial commercial team is in place for a U.S. launch and he hopes to get a pulse on the market's excitement at the conference for the upcoming launch. Rose reiterated his Buy rating and raised his price target to $6 from $5 on Senseonics shares.
News For SENS From the Last 2 Days
There are no results for your query SENS